市场调查报告书
商品编码
1530665
2030 年医疗图像市场预测:按产品、材料、分销管道、应用、最终用户和地区进行的全球分析Medical Imaging Market Forecasts to 2030 - Global Analysis By Product, Material, Distribution Channel, Application, End User and By Geography |
根据Stratistics MRC预测,2024年全球医疗图像市场规模将达437亿美元,预计2030年将达到709亿美元,预测期内复合年增长率为8.4%。
医学影像是一种用于创建身体内部视觉表示以进行临床分析和医疗干预的技术和过程。这些技术包括各种模式,例如 X 光、超音波、电脑断层扫描 (CT)、磁振造影(MRI) 和核子医学影像。每种模式利用不同的原理来捕捉器官、组织和结构的详细影像,以帮助诊断、监测和製定各种医疗状况的治疗计划,确保准确有效的医疗照护。
根据联合国预测,2021年新生儿的平均寿命预计为71岁,比1950年出生的人长近25岁,女性普遍比男性多活5年。
提高人们对早期检测好处的认识
人工智慧诊断和高解析度显像模式等技术进步正在增强早期检测能力,从而提高人们对早期疾病检测益处的认识,并推动市场成长。这有助于及时介入、改善患者治疗效果并降低医疗成本。全球各国政府和医疗保健提供者越来越重视早期检测倡议,刺激了对创新医疗图像技术的需求。
辐射暴露
低剂量电脑断层扫描、剂量监测系统和铅屏蔽的进步等技术可降低风险。诊断功效和辐射安全之间的平衡仍然至关重要,并影响设备的进步和操作通讯协定。持续的技术创新旨在在不影响诊断品质的情况下减少辐射计量,促进跨模式更安全的环境,并改善患者照护和医护人员的安全。这是抑制市场成长的主要因素。
慢性病负担增加
心血管疾病、癌症和神经系统疾病等疾病推动了对 MRI、 电脑断层扫描和超音波等先进影像技术的需求。这些技术能够实现慢性病的早期诊断、治疗计划和监测,有助于扩大市场成长。此外,已开发地区的人口老化和新兴经济体不断扩大的医疗基础设施进一步推动了对医疗图像解决方案的需求。
缺乏合格的人才
缺乏合格的人才是这个市场的一个主要问题。这种短缺影响了影像处理设施的有效运作并延误了患者的治疗。对熟练放射科医生、技术人员和支援人员的需求超过了可用劳动力,特别是在专业领域。解决此问题需要加强培训计画、招募工作和留任策略,以确保充足的人员配备水准并维持高标准的诊断影像服务。
COVID-19 的爆发对市场产生了重大影响,最初扰乱了供应链和选择性程序。然而,远端医疗和基于人工智慧的诊断的引入也在加速。製造商专注于加强消毒通讯协定和开发更安全的成像技术。由于医疗保健挑战持续存在,需要更快的诊断和改善患者的治疗结果,疫情后的恢復看到了对先进成像方式的新投资。
预计在预测期内,乳房X光摄影系统产业将成为最大的产业
预计乳房X光摄影系统将成为预测期内最大的市场。乳房X光摄影系统市场包括用于乳癌筛检和诊断的设备,包括数位和类比系统。主要驱动因素包括乳癌发病率上升以及提高影像品质和患者舒适度的技术进步。市场成长是由意识增强、政府措施和医疗基础设施改善所推动的。
神经病学领域预计在预测期内复合年增长率最高
由于提高影像解析度和效率的技术进步,预计神经学领域在预测期内将出现最高的复合年增长率。功能性 MRI 等先进成像技术可追踪任务期间的大脑活动,有助于规划神经外科手术和研究认知功能。新兴技术包括用于绘製神经连接图的扩散张量成像 (DTI) 和用于检测神经病学生化变化的分子成像。
预计北美在预测期内将占据最大的市场占有率。在慢性病增加、人口老化和医疗保健支出等因素的推动下,该地区在市场规模和创新方面处于世界领先地位。人工智慧和机器学习的不断进步也推动了市场的发展,这些技术正在提高诊断的准确性和效率。法律规范确保病患安全和资料隐私的高标准,从而增强医疗保健提供者和病患之间的信任和信心。
由于医疗保健成本上升、技术进步和诊断程序需求不断增加,预计亚太地区在预测期内将保持最高的复合年增长率。中国、日本、印度和韩国等国家透过扩大医疗基础设施和采用 MRI、CT、超音波和 X 光等诊断影像方式做出了重大贡献。该市场也受到旨在改善全部区域医疗保健的可近性和品质的政府倡议的影响。
According to Stratistics MRC, the Global Medical Imaging Market is accounted for $43.7 billion in 2024 and is expected to reach $70.9 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Medical imaging is technique and process used to create visual representations of the interior of a body for clinical analysis and medical intervention. These techniques include various modalities such as X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging. Each modality utilizes different principles to capture detailed images of organs, tissues, and structures, aiding in the diagnosis, monitoring, and treatment planning of various medical conditions, ensuring precise and effective medical care.
According to the United Nations, a newborn in 2021 is projected to have an average lifespan of nearly 25 years longer than someone born in 1950, achieving an average age of 71 years, with females typically living five years longer than males.
Increasing awareness of the benefits of early disease detection
Increasing awareness of the benefits of early disease detection is driving growth in the market, due to advancement in technology, such as AI-powered diagnostics and high-resolution imaging modalities, enhance early detection capabilities. This fosters timely intervention, improving patient outcomes and reducing healthcare costs. Governments and healthcare providers globally are increasingly prioritizing early detection initiatives, fueling demand for innovative medical imaging technologies.
Radiation exposure
Technologies like low-dose CT scans, dose monitoring systems, and lead shielding advancements mitigate risks. Balancing diagnostic efficacy with radiation safety remains pivotal, influencing equipment advancements and operational protocols. Continuous innovation targets reducing exposure without compromising diagnostic quality, promoting safer environments across modalities, enhancing patient care and healthcare provider safety. This is the major factor impeding the growth of the market.
Rising burden of chronic diseases
Conditions like cardiovascular diseases, cancer, and neurological disorders drive demand for advanced imaging technologies such as MRI, CT scans, and ultrasound. These technologies enable early diagnosis, treatment planning, and monitoring of chronic conditions, contributing to increased market growth. Additionally, aging populations in developed regions and the expanding healthcare infrastructure in emerging economies further propel the demand for medical imaging solutions.
Shortage of qualified personnel
In the market, a significant challenge is the shortage of qualified personnel. This shortage impacts the efficient operation of imaging facilities and delays patient care. The demand for skilled radiologists, technicians, and support staff exceeds the available workforce, especially in specialized fields. Addressing this issue requires enhanced training programs, recruitment initiatives, and retention strategies to ensure adequate staffing levels and maintain high standards of diagnostic imaging services.
The COVID-19 pandemic significantly impacted the market, initially causing disruptions in supply chains and elective procedures. However, it also accelerated the adoption of telemedicine and AI-driven diagnostics. Manufacturers focused on enhancing sanitization protocols and developing safer imaging technologies. Post-pandemic recovery witnessed renewed investments in advanced imaging modalities, driven by the need for faster diagnostics and improved patient outcomes amidst ongoing healthcare challenges.
The mammography systems segment is expected to be the largest during the forecast period
The mammography systems is expected to be the largest during the forecast period. The mammography systems in market encompass devices used for breast cancer screening and diagnosis, including digital and analog systems. Key drivers include rising breast cancer incidence and technological advancements enhancing imaging quality and patient comfort. Market growth is propelled by increased awareness, government initiatives, and healthcare infrastructure development.
The neurology segment is expected to have the highest CAGR during the forecast period
The neurology segment is expected to have the highest CAGR during the forecast period owing to technological advancements enhancing imaging resolution and efficiency. Advanced imaging techniques like functional MRI track brain activity during tasks, aiding in neurosurgical planning and studying cognitive functions. Emerging technologies include diffusion tensor imaging (DTI) for mapping neural connections and molecular imaging for detecting biochemical changes in neurology.
North America is projected to hold the largest market share during the forecast period. The region leads globally in terms of market size and innovation, driven by factors such as increasing chronic diseases, aging population, and healthcare expenditure. The market is also buoyed by ongoing advancements in AI and machine learning, enhancing diagnostic accuracy and efficiency. Regulatory frameworks ensure high standards of patient safety and data privacy, fostering trust and reliability among healthcare providers and patients alike.
Asia Pacific is projected to hold the highest CAGR over the forecast period driven by increasing healthcare expenditure, technological advancements, and rising demand for diagnostic procedures. Countries like China, Japan, India, and South Korea are significant contributors due to their expanding healthcare infrastructure and adoption of diagnostic imaging modalities such as MRI, CT, ultrasound, and X-ray. The market is also influenced by government initiatives aimed at improving healthcare accessibility and quality across the region.
Key players in the market
Some of the key players in Medical Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, Hologic, Inc., Carestream Health, Fujifilm Medical Systems, Samsung Medison, Esaote S.p.A., Konica Minolta Healthcare, Mindray Medical International Limited, Medtronic, Stryker Corporation, Neusoft Medical Systems, Allengers Medical Systems Limited and United Imaging Healthcare.
In January 2024, Canon Medical Systems Corporation along with Olympus Corporation declared their partnership to work together on Endoscopic Ultrasound Systems. Under this agreement, Canon Medical is tasked with the development and manufacturing of diagnostic ultrasound systems for use in Endoscopic Ultrasonography, while Olympus will handle the sales and marketing activities.
In February 2023, GE Healthcare announced that it reached an agreement to acquire a privately held AI healthcare provider, Caption Health, Inc. Caption Health develops clinical applications to help with early disease diagnosis and uses AI to help with ultrasound scans.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.